Cost of disease analysis and cost effectiveness analysis of specific immunotherapy in asthma;Krankheitskosten-studie und kosten-nutzen-analyse der spezifischen immuntherapie bei asthma

Allergo Journal

Volumn 10, Issue 6, 2001, Pages 341-347

  Martens P ^a   Lobermeyer, K ^a  

^a I G Suisse Gesundheitsforschung   (Switzerland)

Author keywords

Asthma; Cost effectiveness analysis; Cost of disease analysis; Specific immunotherapy

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

ARTICLE; ASTHMA; COST BENEFIT ANALYSIS; DISEASE SEVERITY; GERMANY; HEALTH CARE SYSTEM; HUMAN; IMMUNOTHERAPY; TREATMENT INDICATION;

EID: 0034848357     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Immunotherapy in asthma: An updated systematic review
2. Allergen immunotherapy for asthma (Cochrane review)
3. Asthma management - A new dimension
4. Allergen immunotherapy: Therapeutic vaccines for allergic diseases
5. Nutzen der hyposensibilisierung unter wirtschaftlichen aspekten
6. A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract alutard SQ during a 3-year period with initial rush immunotherapy
7. Diseases and their treatment: Asthma
8. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from longterm (6-year) follow-up
9. Bedeutung allergischer faktoren bei patienten mit exazerbationen eines asthma bronchiale
10. Asthma bronchiale eine krankheitskostenanalyse
11. A 1-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults
12. ABC of asthma: Definition and diagnosis
13. Morbidity statistics from general practise
14. Kosten der asthmatherapie nach schweregrad
15. Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trial
16. Asthma